Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 95 | $13,688,765 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Sep 2024 | Sale | 20,000 | 6.14 | 122,800 | D |
06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Sep 2024 | Sale | 20,000 | 6.04 | 120,800 | D |
09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Aug 2024 | Sale | 20,000 | 6.5 | 130,000 | D |
09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Aug 2024 | Sale | 30,000 | 7.1 | 213,000 | D |
12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 11 Jul 2024 | Sale | 50,000 | 7.47 | 373,500 | D |
12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 10 Jul 2024 | Sale | 50,000 | 7.48 | 374,000 | D |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Jun 2024 | Sale | 50,000 | 9 | 450,000 | D |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jun 2024 | Sale | 50,000 | 8.42 | 421,000 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 28,704 | 8.47 | 243,123 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 21,296 | 8.47 | 180,377 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 May 2024 | Sale | 50,000 | 7.73 | 386,500 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 25,000 | 9.02 | 225,500 | I |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 25,000 | 8.84 | 221,000 | I |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 40,000 | 9.02 | 360,800 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 40,000 | 8.84 | 353,600 | D |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 25,000 | 10.1 | 252,500 | I |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 40,000 | 10.1 | 404,000 | D |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 1,000 | 11.5621 | 11,562 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 20,000 | 11.5501 | 231,002 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 4,000 | 11.5648 | 46,259 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 36,319 | 11.8583 | 430,682 | D |
09 Feb 2024 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Feb 2024 | Sale | 48,272 | 9.2182 | 444,981 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 1,000 | 9.4939 | 9,494 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 20,000 | 9.512 | 190,240 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 4,000 | 9.5073 | 38,029 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 30,853 | 9.4903 | 292,804 | D |
08 Dec 2023 17:22 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Dec 2023 | Sale | 59,829 | 7.4946 | 448,394 | D |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 1,000 | 5.137 | 5,137 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 20,000 | 5.1147 | 102,294 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 4,000 | 5.1411 | 20,564 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 37,177 | 5.1996 | 193,306 | D |
06 Oct 2023 18:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Oct 2023 | Sale | 59,794 | 7.2085 | 431,025 | D |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 1,000 | 8.8363 | 8,836 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 20,000 | 8.8348 | 176,696 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 4,000 | 8.8337 | 35,335 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 33,765 | 8.7835 | 296,575 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 4,060 | 13.3631 | 54,254 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 60,955 | 13.0171 | 793,457 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 13 | 14.85 | 193 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 63 | 13.7541 | 867 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 12.3559 | 1,569 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 561 | 11.8245 | 6,634 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 550 | 14.0291 | 7,716 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 236 | 10.8698 | 2,565 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,693 | 12.4131 | 58,255 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 10,327 | 11.7442 | 121,282 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,430 | 10.8382 | 48,013 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 14.0601 | 1,786 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 12.4076 | 10,546 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 2,173 | 11.8005 | 25,642 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 10.8206 | 9,198 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 17,227 | 14.344 | 247,104 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,270 | 12.3873 | 40,506 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 7,898 | 11.7969 | 93,172 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,423 | 10.8658 | 37,194 | D |
09 Jun 2023 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jun 2023 | Sale | 56,436 | 9.0511 | 510,808 | D |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 1,000 | 4.9151 | 4,915 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 20,000 | 4.9018 | 98,036 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 4,000 | 4.9058 | 19,623 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 33,073 | 4.7096 | 155,761 | D |
28 Apr 2023 16:32 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2022 | Sale A | 18,500 | 7.3875 | 136,669 | D |
07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Apr 2023 | Sale | 40,000 | 6.6418 | 265,672 | D |
07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Apr 2023 | Sale | 13,327 | 6.4559 | 86,038 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 09 Mar 2023 | Sale | 15,000 | 7.7747 | 116,620 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 1,000 | 8.0867 | 8,087 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 20,000 | 8.095 | 161,900 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 4,000 | 8.0904 | 32,362 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 70,890 | 8.096 | 573,925 | D |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9086 | 7,909 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9059 | 7,906 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 500 | 7.9041 | 3,952 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 18,500 | 7.919 | 146,502 | D |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2017 | 9,202 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2075 | 9,208 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 500 | 9.2082 | 4,604 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 18,500 | 9.2188 | 170,548 | D |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3822 | 7,382 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3907 | 7,391 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 500 | 7.3789 | 3,689 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 18,500 | 7.3875 | 136,669 | D |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 500 | 9.2648 | 4,632 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 18,500 | 9.2765 | 171,615 | D |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 18,710 | 8.7731 | 164,145 | D |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0993 | 10,099 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0984 | 10,098 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 500 | 10.1104 | 5,055 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 18,500 | 10.1101 | 187,037 | D |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 18,193 | 9.889 | 179,911 | D |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6414 | 11,641 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6428 | 11,643 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 500 | 11.6421 | 5,821 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 18,500 | 11.6514 | 215,551 | D |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 17,553 | 11.5033 | 201,917 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)